Riverside invests Oz medical evaluator MLCOA
Global SME-focused private equity firm The Riverside Company has invested an undisclosed sum in Australian medical consultancy MLCOA, marking Riverside’s second acquisition in the market.
The investment is Riverside's third in Asia Pacific in the last month, and is its first healthcare acquisition and third investment from its Riverside Asia Fund I, launched in 2007. Melbourne-based MLCOA specializes in medical assessments for insurance, corporate, government and legal organizations, providing more than 25,000 services annually.
The news comes during an active period for Riverside in Asia Pacific. Riverside just announced its second investment into Naka & Co., Ltd., a manufacturer and distributor of crystal oscillators. Earlier this month, Riverside reportedly acquired Boost Investment Group in Australia, the holding company of Boost Juice Bars and Salsa's Fresh Mex Grill.
More on Investments
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.